New pill tested to fight sudden sleep attacks

NCT ID NCT07363720

Recruiting now Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

Summary

This study is testing a pill called TAK-861 to see if it can help control the symptoms of narcolepsy type 1, a sleep disorder that causes severe daytime sleepiness and sudden muscle weakness (cataplexy). About 88 adults with this condition will take the drug for several months, and then some will be switched to a placebo (dummy pill) to see if their symptoms return. The main goal is to find out if the drug's effect lasts and how safe it is.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 (NT1) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Takeda Site 1
RECRUITING

Redwood City, California, 94063, United States
Takeda Site 2
RECRUITING

Cincinnati, Ohio, 45245, United States
Takeda Site 3
RECRUITING

Columbia, South Carolina, 29201, United States
Takeda Site 4
RECRUITING

Brandon, Florida, 33511, United States
Takeda Site 5
RECRUITING

Austin, Texas, 78731, United States
Takeda Site 6
RECRUITING

Miami, Florida, 33155, United States
Takeda Site 7
RECRUITING

Southfield, Michigan, 48075, United States

Conditions

Explore the condition pages connected to this study.

NARCOLEPSY TYPE 1 (NT1) NARCOLEPSY WITH CATAPLEXY